- Home
- HKPD vs CLRB Comparison
HKPD vs CLRB Comparison
Compare HKPD & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HKPD
- CLRB
- Stock Information
- Founded
- HKPD 2016
- CLRB 2002
- Country
- HKPD Hong Kong
- CLRB United States
- Employees
- HKPD N/A
- CLRB N/A
- Industry
- HKPD Other Pharmaceuticals
- CLRB Biotechnology: Pharmaceutical Preparations
- Sector
- HKPD Health Care
- CLRB Health Care
- Exchange
- HKPD Nasdaq
- CLRB Nasdaq
- Market Cap
- HKPD 20.9M
- CLRB 17.6M
- IPO Year
- HKPD 2025
- CLRB N/A
- Fundamental
- Price
- HKPD $1.28
- CLRB $5.03
- Analyst Decision
- HKPD
- CLRB Hold
- Analyst Count
- HKPD 0
- CLRB 2
- Target Price
- HKPD N/A
- CLRB N/A
- AVG Volume (30 Days)
- HKPD 857.7K
- CLRB 278.7K
- Earning Date
- HKPD 01-01-0001
- CLRB 08-12-2025
- Dividend Yield
- HKPD N/A
- CLRB N/A
- EPS Growth
- HKPD N/A
- CLRB N/A
- EPS
- HKPD 0.21
- CLRB N/A
- Revenue
- HKPD $20,770,344.00
- CLRB N/A
- Revenue This Year
- HKPD N/A
- CLRB N/A
- Revenue Next Year
- HKPD N/A
- CLRB N/A
- P/E Ratio
- HKPD $6.09
- CLRB N/A
- Revenue Growth
- HKPD 32.91
- CLRB N/A
- 52 Week Low
- HKPD $0.81
- CLRB $4.36
- 52 Week High
- HKPD $3.79
- CLRB $94.50
- Technical
- Relative Strength Index (RSI)
- HKPD N/A
- CLRB 32.91
- Support Level
- HKPD N/A
- CLRB $4.36
- Resistance Level
- HKPD N/A
- CLRB $8.30
- Average True Range (ATR)
- HKPD 0.00
- CLRB 1.28
- MACD
- HKPD 0.00
- CLRB -0.72
- Stochastic Oscillator
- HKPD 0.00
- CLRB 4.81
About HKPD Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.